Alberto Zambelli - Istituti Clinici Scientifici Maugeri IRCCS

基本信息

浏览量：1

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 270 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

pionERA Breast Cancer (BC): Phase III study of first-line (1L) giredestrant vs. fulvestrant, both combined with a cyclin-dependent kinase 4/6 inhibitor (CDK4/6i), in patients (pts) with estrogen receptor-positive (ER+), HER2– locally advanced/metastatic BC (LA/mBC) with resistance to prior adjuvant (adj) endocrine therapy (ET)

Kevin Kalinsky,Rinath Jeselsohn,Meritxell Bellet, Peter A. Fasching,Gonzalo Gomez-Abuin,Kyung Hae Jung, Sandrine Lavallé,Vanesa López-Valverde,Yen-Shen Lu,Richard B. Schwab,Nick Turner,Vanessa Breton,Alberto Zambelli,Fabrice Andre

Journal of Clinical Oncologyno. 16_suppl (2024)

引用0浏览0引用

Bone-active Drugs in Pre-Menopausal Women with Breast Cancer Undergoing Hormone Deprivation Therapies

Maria Francesca Birtolo, Rebecca Pedersini,Andrea Palermo, Walter Vena, Emanuela Morenghi, Giacomo Cristofolini, Barbara Presciuttini,Gaia Tabacco,Anda Mihaela Naciu, Stella Pigni, Marta Lagana, Federica Mazzoleni, Deborah Cosentini, Antea Ciafardini,Mauro Pagani,Davide Farina, Luca Balzarini,Alberto Zambelli,Rosalba Torrisi, Luisella Cianferotti, Nicola Napoli, Bruno Giorda Carlo,Andrea Lania,Alfredo Berruti,Gherardo Mazziotti

Endocrine Abstracts (2024)

引用0浏览0引用

Pionera Breast Cancer (BC): Phase III Study of First-Line (1L) Giredestrant Vs. Fulvestrant, Both Combined with a Cyclin-Dependent Kinase 4/6 Inhibitor (cdk4/6i), in Patients (pts) with Estrogen Receptor-Positive (ER+), HER2-locally Advanced/metastatic BC (la/mbc) with Resistance to Prior Adjuvant (adj) Endocrine Therapy (ET)

Kevin Kalinsky,Rinath Jeselsohn,Meritxell Bellet,Peter A. Fasching,Gonzalo Gomez-Abuin,Kyung Hae Jung, Sandrine Lavalle,Vanesa L. Prime Opez-Valverde,Yen-Shen Lu,Richard B. Schwab,Nick Turner,Vanessa Breton,Alberto Zambelli,Fabrice Andre

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2024)

引用0浏览0引用

Empowering beyond Pain: Pain Neuroscience Education Interventions in Breast Cancer Survivorship Care

Marco Balordi,Paola Tiberio,Matteo Castaldo,Alessandro Viganò,Flavia Jacobs,Alberto Zambelli,Armando Santoro,Rita De Sanctis

Cancersno. 16 (2024)

引用0浏览0WOS引用

Unlocking Methodological Insights on Oncology Efficacy Endpoints: from Statistical to Clinical and Vice Versa. Letter to the Editor Regarding 'abemaciclib Plus a Nonsteroidal Aromatase Inhibitor As Initial Therapy for HR+, HER2- Advanced Breast Cancer: Final Overall Survival Results of MONARCH 3' by M. P. Goetz Et Al

R. De Sanctis, P. Bruzzi,A. Zambelli

Annals of Oncology（2024）

引用0浏览0WOS引用

BRCATesting for Patients Treated in Italy: A National Survey of Breast Centers Associated with Senonetwork

Corrado Tinterri,Damiano Gentile,Francesco Caruso,Laura Cortesi, Michelino De Laurentiis,Lucio Fortunato,Donatella Santini, Daniela Turchetti,Alberta Ferrari,Alberto Zambelli

CURRENT ONCOLOGYno. 7 (2024): 3815-3825

引用0浏览0WOS引用

Unveiling the HER2-low Phenomenon: Exploring Immunohistochemistry and Gene Expression to Characterise HR-positive HER2-negative Early Breast Cancer

M. Gaudio,F. Jacobs,C. Benvenuti,G. Saltalamacchia,R. Gerosa,R. De Sanctis, A. Santoro,A. Zambelli

BREAST CANCER RESEARCH AND TREATMENTno. 3 (2024): 487-495

引用1浏览0WOS引用

The I2b2 Temporal Data-Mining Solution for Automated Reconstruction of Different Breast Cancer Patterns of Care over a Decade of Observation

Alberto Zambelli,Flavia Jacobs, Arianna Ghirardi, Lorenzo Chiudinelli, Mauro Bucalo, Nicola Barbarini, Sara D’Alessandro, Arianna Masciulli, Vittoria Fotia,Riccardo Bellazzi, Carlo Tondini

Journal of Biomedical Research & Environmental Sciencesno. 6 (2024): 630-639

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn